Influence of endothelium in dose-dependent inhibition and potentiation by isoniazid of isosorbide dinitrate relaxation of rat aorta

Journal of Cardiovascular Pharmacology
H Vidrio, G Fernández

Abstract

The influence of in vivo administration of isoniazid on the relaxant effect of isosorbide dinitrate was determined by pretreating rats with various doses of isoniazid and obtaining concentration-response curves to isosorbide dinitrate in aortic rings from these animals. In rings with endothelium, isoniazid potentiated responses to isosorbide dinitrate at doses of 10, 30, and 100 mg/kg; 3 and 300 mg/kg were without effect. In endothelium-denuded preparations, potentiation was present only at 10 mg/kg; 3 and 300 mg/kg inhibited relaxation. Other experiments indicated that isoniazid potentiation was prevented by pyridoxine, was reproduced with theophylline, and did not occur with 3-morpholinosydnonimine or papaverine. These results were deemed compatible with the hypothesis that isoniazid inhibits transsulfuration of homocysteine and causes its accumulation in vascular smooth muscle and endothelial cells, where it functions as a thiol intermediate and leads to enhanced bioactivation of isosorbide dinitrate. Potentiation appeared to occur only with moderate increases of homocysteine.

References

Sep 24, 1992·The American Journal of Cardiology·H L FungE A Kowaluk
Oct 15, 1991·Biochemical and Biophysical Research Communications·M Feelisch, M Kelm
Mar 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·S MoncadaR M Palmer
Mar 1, 1985·American Heart Journal·W R Kukovetz, S Holzmann
Apr 23, 1985·European Journal of Pharmacology·C A Gruetter, S M Lemke
Jan 1, 1988·European Heart Journal·K SchrörE König
Mar 1, 1981·The Journal of Clinical Investigation·R I LevinK Tack-Goldman
Nov 30, 1995·Biochimica Et Biophysica Acta·J S MatthewsM Keen
Mar 1, 1993·Journal of Cardiovascular Pharmacology·P UngerJ Fontaine
Jul 1, 1994·Trends in Pharmacological Sciences·B M BennettW C Simon
Sep 1, 1993·Annals of Internal Medicine·P F Barnes, S A Barrows
Jun 1, 1993·European Journal of Pharmacology·K S ParkB J Song
Oct 1, 1993·Pediatric Clinics of North America·E A RosenfeldR Yogev
Jul 1, 1996·The Journal of Clinical Investigation·J B UbbinkW J Vermaak
Jul 1, 1996·The Journal of Clinical Investigation·S R LentzD D Heistad
Jan 1, 1996·Nutrition·H M Delany
Nov 14, 1997·Biochemical Pharmacology·P Lainé-CessacP Allain
Sep 11, 1998·Journal of Cardiovascular Pharmacology·H Vidrio, G Fernández
Aug 17, 1999·Annual Review of Nutrition·J Selhub
Feb 17, 2000·Arteriosclerosis, Thrombosis, and Vascular Biology·D LangM J Lewis

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.